HydroSoft 3D 7110-0304-3D-A2Recalls & reported problems
Microvention, Inc. · V-Trak · Class 2 · Implant
All models of HydroSoft 3D (26)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00816777025456), received between Sep 6, 2023 and Nov 10, 2024 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Component Missing” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Component Missing1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Aneurysm1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryNov 10, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AS REPORTED THROUGH THE RAGE CLINICAL STUDY: RECEIVED RETREATMENT DATA FROM THE STUDY TEAM FOR REVIEW. EVENT INFORMATION EVENT DATE: 04/NOV/2020 PROCEDURE DATE: (B)(6) 2019 TARGET ANEURYSM INFORMATION: ANEURYSM LOCATION: POSTERIOR COMMUNICATING (PCOM) OTHER ANEURYSM LOCATION: ANEURYSM SIDE: LEFT HEIGHT: 4.7MM WIDTH: 2.3MM DEPTH: 2.6MM NECK SIZE: 1.9MM DOME TO NECK RATIO: 1.21MM. EVENT DESCRIPTION: CEREBRAL ANGIOGRAPHY DEMONSTRATED COIL COMPACTION AND RECURRENCE AT THE BASE OF THE ANEURYSM. THE SUBJECT UNDERWENT RETREATMENT WITH CLIPPING. DEVICE INFORMATION THAT WAS USED IN INDEX PROCEDURE. AS IT CANNOT BE DETERMINED WHICH COIL DEVICE MAY HAVE IMPACTED THE ANEURYSM RECURRENCE THE HYDROSOFT 3D- 3X4 WAS CHOSEN AS A DEFAULT. THE OTHER COIL USED IN THE PROCEDURE WILL BE LISTED AS CONCOMITANT DEVICE. 1. HYDROSOFT 3D 3X4- DETACHED 2. HYDROSOFT 3D 1.5X2- DETACHED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20649469 ↗InjurySep 2, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
AS REPORTED THROUGH THE RAGE CLINICAL STUDY: BELOW EVENT WAS REVIEWED BY INDEPENDENT REVIEWER (CEA) AND WAS DETERMINED TO BE DEFINITELY RELATED TO STUDY DEVICE AND PROBABLY RELATED TO STUDY PROCEDURE. EVENT INFORMATION: EVENT TERM: ANEURYSM RECURRENCE EVENT #: 2 EVENT START DATE: 20/FEB/2020 POST OPERATIVE DAYS: 211 DAYS EVENT DESCRIPTION : RECURRENCE ORIGINALLY FOUND 2/20/2020. DURING A CONSULT ON 1/15/2021 SUBJECT DISCUSSED RECURRENCE AND WANTING TREATMENT. SUBJECT HAD A 1.6 X 1.4 MM RECURRENCE AT THE BASE OF THIS ANEURYSM. PER TREATING PHYSICIAN THE RECURRENCE HAD A VERY LOW RISK OF RUPTURE. HOWEVER, THE PATIENT REPORTS DEBILITATING ANXIETY ABOUT FUTURE ANEURYSM-RELATED EVENTS THAT CULMINATED IN AN INPATIENT HOSPITALIZATION LAST MONTH FOLLOWING A SUICIDE ATTEMPT. DESPITE THE LOW NATURAL HISTORY RISK OF THE RECURRENT ANEURYSM, SUBJECT EXPRESSED THEY COULD NOT HANDLE THE THOUGHT OF GOING THROUGH ANOTHER ANEURYSM RUPTURE, AND THAT TAKING THE RISK OF ANEURYSM RUPTURE TO ZERO WOULD DRAMATICALLY IMPROVE ANXIETY. EMBOLIZATION PERFORMED ON (B)(6) 2021. FOLLOW UP ANGIOGRAM ON 10/8/2021 SHOWED COMPLETE OCCLUSION WITH NO RECURRENCE. AE OUTCOME : RESOLVED WITHOUT SEQUELAE DEVICES USED: HYDR
Patient problems: Aneurysm
MAUDE report 20116750 ↗MalfunctionSep 6, 2023Component Missing; Component Missing
SEE SECTION H10 FOR INVESTIGATION RESULTS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17695077 ↗
Other Device, Vascular, for Promoting Embolization devices
- POD RBYPOD8-APenumbra, Inc. · Device, Vascular, For Promoting Embolization195 reports
- CEREPAKTM MDH1Cerenovus, Inc. · Device, Vascular, for Promoting Embolization1 recall72 reports
- Azur CX Detachable 45-750824Microvention, Inc. · Device, Vascular, for Promoting Embolization115 reports
- Tornado G08261Cook Incorporated · Device, Vascular, for Promoting Embolization2 recalls7 reports
- Optima Coil System OPTI0930CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0720CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls4 reports
- Optima Coil System OPTI0413CSFMXBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
- Prestige Coil System PRES0520HPKPLBalt USA LLC · Device, Vascular, For Promoting Embolization2 recalls3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page